vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Simulations Plus, Inc.（SLP）财务数据对比。点击上方公司名可切换其他公司
Simulations Plus, Inc.的季度营收约是CAPRICOR THERAPEUTICS, INC.的1.7倍（$18.4M vs $11.1M），Simulations Plus, Inc.净利率更高（3.7% vs -63.9%，领先67.6%），Simulations Plus, Inc.同比增速更快（-2.7% vs -7.9%），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs 0.3%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
CAPR vs SLP — 直观对比
营收规模更大
SLP
是对方的1.7倍
$11.1M
营收增速更快
SLP
高出5.3%
-7.9%
净利率更高
SLP
高出67.6%
-63.9%
两年增速更快
CAPR
近两年复合增速
0.3%
损益表 — Q4 FY2024 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $18.4M |
| 净利润 | $-7.1M | $676.0K |
| 毛利率 | — | 59.1% |
| 营业利润率 | -69.1% | 3.9% |
| 净利率 | -63.9% | 3.7% |
| 营收同比 | -7.9% | -2.7% |
| 净利润同比 | -833.8% | 228.2% |
| 每股收益（稀释后） | $-0.11 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRSLP
| Q4 25 | — | $18.4M | ||
| Q3 25 | — | $17.5M | ||
| Q2 25 | — | $20.4M | ||
| Q1 25 | — | $22.4M | ||
| Q4 24 | $11.1M | $18.9M | ||
| Q3 24 | $2.3M | $18.7M | ||
| Q2 24 | $4.0M | $18.5M | ||
| Q1 24 | $4.9M | $18.3M |
净利润CAPRSLP
| Q4 25 | — | $676.0K | ||
| Q3 25 | — | $-681.0K | ||
| Q2 25 | — | $-67.3M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | $-7.1M | $206.0K | ||
| Q3 24 | $-12.6M | $843.0K | ||
| Q2 24 | $-11.0M | $3.1M | ||
| Q1 24 | $-9.8M | $4.0M |
毛利率CAPRSLP
| Q4 25 | — | 59.1% | ||
| Q3 25 | — | 56.4% | ||
| Q2 25 | — | 64.0% | ||
| Q1 25 | — | 58.5% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.2% |
营业利润率CAPRSLP
| Q4 25 | — | 3.9% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | -364.5% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | -69.1% | 0.7% | ||
| Q3 24 | -575.2% | -6.2% | ||
| Q2 24 | -291.9% | 10.1% | ||
| Q1 24 | -209.2% | 24.3% |
净利率CAPRSLP
| Q4 25 | — | 3.7% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | — | -330.6% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | -63.9% | 1.1% | ||
| Q3 24 | -555.2% | 4.5% | ||
| Q2 24 | -277.0% | 16.9% | ||
| Q1 24 | -199.6% | 22.0% |
每股收益（稀释后）CAPRSLP
| Q4 25 | — | $0.03 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-3.35 | ||
| Q1 25 | — | $0.15 | ||
| Q4 24 | $-0.11 | $0.01 | ||
| Q3 24 | $-0.38 | $0.04 | ||
| Q2 24 | $-0.35 | $0.15 | ||
| Q1 24 | $-0.31 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $35.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $127.1M |
| 总资产 | $170.5M | $137.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRSLP
| Q4 25 | — | $35.7M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $21.4M | ||
| Q4 24 | $151.5M | $18.2M | ||
| Q3 24 | $85.0M | $20.3M | ||
| Q2 24 | $29.5M | $119.0M | ||
| Q1 24 | $39.9M | $108.5M |
股东权益CAPRSLP
| Q4 25 | — | $127.1M | ||
| Q3 25 | — | $124.8M | ||
| Q2 25 | — | $123.8M | ||
| Q1 25 | — | $189.5M | ||
| Q4 24 | $145.5M | $184.7M | ||
| Q3 24 | $68.3M | $182.4M | ||
| Q2 24 | $11.5M | $180.9M | ||
| Q1 24 | $18.4M | $177.0M |
总资产CAPRSLP
| Q4 25 | — | $137.8M | ||
| Q3 25 | — | $131.9M | ||
| Q2 25 | — | $134.4M | ||
| Q1 25 | — | $201.4M | ||
| Q4 24 | $170.5M | $196.9M | ||
| Q3 24 | $93.0M | $196.6M | ||
| Q2 24 | $38.3M | $192.7M | ||
| Q1 24 | $49.4M | $194.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $4.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | — |
| 自由现金流率自由现金流/营收 | -137.3% | — |
| 资本支出强度资本支出/营收 | 4.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 6.26× |
| 过去12个月自由现金流最近4个季度 | $-41.2M | — |
8季度趋势，按日历期对齐
经营现金流CAPRSLP
| Q4 25 | — | $4.2M | ||
| Q3 25 | — | $5.6M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | $-14.8M | $-1.3M | ||
| Q3 24 | $-11.6M | $1.7M | ||
| Q2 24 | $-12.3M | $5.7M | ||
| Q1 24 | $-1.3M | $5.8M |
自由现金流CAPRSLP
| Q4 25 | — | — | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | $-15.3M | $-1.4M | ||
| Q3 24 | $-11.7M | $1.6M | ||
| Q2 24 | $-12.3M | $5.6M | ||
| Q1 24 | $-1.9M | $5.4M |
自由现金流率CAPRSLP
| Q4 25 | — | — | ||
| Q3 25 | — | 30.5% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 25.0% | ||
| Q4 24 | -137.3% | -7.2% | ||
| Q3 24 | -515.2% | 8.8% | ||
| Q2 24 | -310.9% | 30.0% | ||
| Q1 24 | -38.3% | 29.4% |
资本支出强度CAPRSLP
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 4.4% | 0.5% | ||
| Q3 24 | 0.4% | 0.1% | ||
| Q2 24 | 1.5% | 0.6% | ||
| Q1 24 | 12.4% | 2.4% |
现金转化率CAPRSLP
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | -6.18× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
